Role of dietary antioxidants in human metapneumovirus infection

Narayana Komaravelli1, John P Kelley1, Matteo P Garofalo1

  • 1Departments of Pediatrics, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.

Virus Research
|February 4, 2015
PubMed

Insights

Dietary antioxidants like resveratrol and quercetin can combat human metapneumovirus (hMPV) by reducing oxidative stress and inflammation. These compounds inhibit hMPV replication and inflammatory responses, offering a potential treatment for hMPV infections.

Area of Science:

  • Virology
  • Immunology
  • Nutritional Science

Background:

  • Human metapneumovirus (hMPV) causes significant respiratory illness, with no current vaccines or treatments.
  • Oxidative stress and inflammation are key mechanisms in hMPV pathogenesis.

Purpose of the Study:

  • To investigate the protective effects of dietary antioxidants against hMPV infection.
  • To explore the potential of resveratrol and quercetin as therapeutic agents for hMPV.

Main Methods:

  • Airway epithelial cells were treated with resveratrol and quercetin during hMPV infection.
  • Assessed cellular oxidative damage, inflammatory mediator secretion, and viral replication.
  • Analyzed viral gene transcription, protein synthesis, and transcription factor activity (NF-κB, IRF-3).

Main Results:

  • Resveratrol and quercetin significantly reduced oxidative damage, inflammation, and viral replication.
  • Inhibition of viral replication occurred at the assembly/release stage, not transcription or translation.
  • Antioxidant treatment modulated inflammatory mediator expression by inhibiting NF-κB and IRF-3.

Conclusions:

  • Dietary antioxidants show promise in mitigating hMPV-induced lung damage and inflammation.
  • Resveratrol and quercetin represent a potential therapeutic strategy for hMPV infections.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
688
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
42
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.7K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
45
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
67
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.5K